Exercise Training and Heart Rate Variability: A Guided Optimization of Cardiorespiratory Fitness in Cardiometabolic Disease.

Authors

Michael F Mendoza, Michael A Anzelmo, Alex A Rojas, Nina M Suan, Carl J Lavie

Published in

Current atherosclerosis reports. Volume 28. Issue 1. Aug 06, 2026. Epub Aug 06, 2026.

Abstract

To examine the role of exercise training (ET), cardiorespiratory fitness (CRF), and heart rate variability (HRV)-guided training in reducing cardiometabolic risk associated with type 2 diabetes (T2DM), obesity, and metabolic syndrome (MetS), and to discuss the emerging clinical utility of wearable HRV-monitoring devices.
Low CRF is one of the strongest predictors of all-cause and cardiovascular disease (CVD) mortality, often surpassing traditional CVD risk factors such as obesity, hypertension, dyslipidemia, and T2DM. Increasing evidence supports CRF as a clinical vital sign, with each 1-metabolic equivalent increase associated with significant reductions in mortality risk. Both aerobic ET (aET) and resistance ET (rET) improve CRF and metabolic health through mechanisms involving enhanced glucose regulation, mitochondrial biogenesis, endothelial function, lipoprotein remodeling, autonomic balance, and reduced systemic inflammation. High-intensity interval training consistently produces greater maximal oxygen consumption (VO₂max) improvements than moderate-intensity continuous training, although excessive high-intensity ET without adequate recovery may impair adaptation. HRV-guided ET has emerged as a practical strategy to individualize ET intensity based on autonomic readiness, improving training efficiency while reducing excessive physiological strain and overtraining risk. Contemporary consumer wearable devices (CWDs), including WHOOP, Oura Ring, Apple Watch, Garmin, and Polar systems, increasingly allow real-time HRV monitoring outside clinical settings. ET remains a foundational therapy for cardiometabolic disease prevention and management. Current evidence supports prioritizing CRF optimization over weight-centric approaches alone, as higher CRF levels substantially attenuate mortality risk independent of adiposity. HRV-guided ET further enhances individualized ET prescription by aligning exercise intensity with physiologic recovery status. As wearable technology continues to evolve, HRV-monitoring CWDs may provide scalable tools to improve ET personalization, recovery monitoring, and long-term cardiometabolic health outcomes.

PMID:
42560414
Bibliographic data and abstract were imported from PubMed on 06 Aug 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.